GBS GLUCOSE BIOSENSOR SYS

Intelligent Bio Solutions Inc. Announces Leading U.K. Container Haulier Switching to Fingerprint Drug Screening System for In-house Testing

Intelligent Bio Solutions Inc. Announces Leading U.K. Container Haulier Switching to Fingerprint Drug Screening System for In-house Testing

Goldstar Transport to Remove Urine Testing for Sweat Based Technology

NEW YORK, Oct. 31, 2022 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (the "Company”), a life sciences company delivering intelligent, non-invasive, real-time testing solutions, today announced that Goldstar Transport, the UK’s market-leading container haulier, has switched out urine tests for fingerprint drug testing. Goldstar employs approximately 600 LGV drivers, 170 office staff and 40 container lifter staff and is now using fingerprint drug testing to promote health & safety adherence across its 14 site UK-wide operations. Goldstar purchased six Intelligent Fingerprinting portable readers and has been conducting random drug tests each month to adhere to FORS (Fleet Operator Recognition Scheme) guidelines, whilst also using the in-house system to support for cause testing.

Nick Tolley, Driver Compliance Manager, Midlands Depot Manager for Goldstar said: “We have been tracking fingerprint drug testing carefully, and with more and more companies switching from urine to fingerprint sweat for workplace drug testing I can now see why! We’ve purchased six readers to use across our 14 sites and, together with the single use sample collection cartridges, we can do the initial random and suspicion drug testing ourselves in-house.

“The Intelligent Fingerprinting approach is much more hygienic and less intrusive for both our employees as well as those in charge of the testing. It takes less time so has less impact on productivity – saving 5-10 minutes on each test soon adds up!” continued Nick. “Drivers consistently provide a fingerprint sweat sample, so we aren’t subject to the delays due to not being able to gather a sample etc, and we have on site results in 10 minutes. The Intelligent Fingerprinting solution is a lot more straightforward!”

Harry Simeonidis, President and CEO of Intelligent Bio Solutions Inc. said “Substance abuse in society and the workplace is growing at alarming rates and there is a need to increase workplace screening to ensure the safety and wellbeing of employees and the general population. More and more customers are now moving away from Urine and Saliva testing and adopting our safe, efficient, and easy to use test, I believe that this will be the new standard for all companies driving safety in the workplace.”



Terry Elvin, Goldstar’s Account Manager for Intelligent Fingerprinting solutions at Intelligent Bio Solutions, added: “fingerprint drug testing is reliable, accurate and saves time and therefore costs for our clients – not only in the transport and logistics space but in other workplaces as well. With six readers across 11 locations the Goldstar team has the in-house facilities to test as and when they like, enabling the company to positively promote driver safety.”

Fingerprint-based drug testing – how it works:

Intelligent Fingerprinting’s drug testing system features a small, tamper-evident drug screening cartridge onto which ten fingerprint sweat samples are collected, in a process which takes less than a minute. The Intelligent Fingerprinting portable analysis unit then reads the cartridge and provides a positive or negative result on-screen for all drugs in the test in ten minutes.

About Intelligent Bio Solutions Inc.

Intelligent Bio Solutions Inc. is a life sciences company delivering intelligent, non-invasive, real-time testing solutions to customers globally. With its world-first Biosensor Platform, Intelligent Bio Solutions is developing and launching diagnostic tests urgently needed to help people living with chronic disease. In addition, through its recent acquisition of Intelligent Fingerprinting, the company is the world leader in the advancement of portable drugs of abuse testing through the analysis of fingerprint sweat. The test is non-invasive, hygienic, fast, and cost-effective, and screens for recent use of opioids, cocaine, methamphetamines, benzodiazepines and marijuana. Sample collection takes just seconds, with results in ten minutes. A laboratory confirmation service is also available. The system has applications within many sectors, and customers include employers in safety-critical industries such as construction, transport and logistics firms, drug treatment organizations, as well as UK coroners.

About Goldstar Transport

With its head office in Felixstowe, Goldstar has an extensive UK network of 14 depots across England. The company was established in 1998 with a fleet of four Scanias. By 2015 annual turnover hit more than £110 million, with Goldstar handling over 1,400 movements per day. The company specialises in container transport, specialist trailer services and expertise for non-standard jobs and provides off-dock storage facilities at four key locations around the UK testing for patients and their primary health practitioners at point of care, today announced

Company Contact:

Alex Arzeno – Vice President of IR & Communications

Intelligent Bio Solutions Inc.

Investor Contact:

Tim McCarthy – Managing Director

LifeSci Advisors, LLC

Media Contact:

Cheryl Billson

Comma Communications



EN
31/10/2022

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on GLUCOSE BIOSENSOR SYS

 PRESS RELEASE

Intelligent Bio Solutions Reports Fiscal 2025 Fourth Quarter and Full ...

Intelligent Bio Solutions Reports Fiscal 2025 Fourth Quarter and Full Year Results, Highlighting Progress on Planned U.S. Market Expansion, Revenue Growth and Increased Operational Efficiencies Company advanced efforts to secure U.S. FDA 510(k) clearance to advance on path towards planned U.S. market expansion beyond Forensic Use Only settings Fourth quarter sequential and year-on-year revenue growth of 16%, supported by increased demand for drug testing cartridges NEW YORK, Aug. 15, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medi...

 PRESS RELEASE

Intelligent Bio Solutions to Participate in the Sidoti Micro-Cap Virtu...

Intelligent Bio Solutions to Participate in the Sidoti Micro-Cap Virtual Conference on August 20-21, 2025 NEW YORK, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing and screening solutions, today announced that its management team will participate in the Sidoti Micro-Cap Virtual Conference being held on August 20-21, 2025. Presentation DetailsDate: Thursday, August 21, 2025Time: 9:15 a.m. Eastern TimeRegistration/Webcast Link: For more information a...

 PRESS RELEASE

Intelligent Bio Solutions Announces Preliminary Fiscal Fourth Quarter ...

Intelligent Bio Solutions Announces Preliminary Fiscal Fourth Quarter Revenue with Double-Digit Sequential and Year-Over-Year Growth and Strong Operational Momentum Company anticipates fiscal fourth quarter sequential and year-on-year revenue growth of approximately 16% Company advanced efforts to secure U.S. FDA 510(k) clearance for planned U.S. market entry and strengthened global readiness through system upgrades and localization NEW YORK, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering...

 PRESS RELEASE

Intelligent Bio Solutions Secures Major Drug Testing Tender with Leadi...

Intelligent Bio Solutions Secures Major Drug Testing Tender with Leading London Transport Operator NEW YORK, July 30, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced it has secured a major contract with one of London's largest public transport operators, spanning 14 operational sites in greater London and employing over 4,400 staff. INBS's Intelligent Fingerprinting Drug Screening System will be deployed across a multi-garage bus ne...

 PRESS RELEASE

Intelligent Bio Solutions Inc. Enters Into Agreements to Raise $3.8 Mi...

Intelligent Bio Solutions Inc. Enters Into Agreements to Raise $3.8 Million in Gross Proceeds Proceeds to Fund Completion of the Company’s 510k Filing with the U.S. FDA for its Fingerprint Drug Screening System NEW YORK, July 25, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced an agreement between the Company and several current warrant holders to exercise (or prepay the exercise price) certain existing warrants to purchase up to 2...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch